+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Obesity (Metabolic Disorder) - Drugs in Development, 2021

  • ID: 5473080
  • Report
  • October 2021
  • Region: Global
  • 763 Pages
  • Global Markets Direct
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Drugs In Development, 2021, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape. Obesity is defined as having an excessive amount of body fat. Obesity increases risk of diseases and health problems such as heart disease, diabetes and high blood pressure. The predisposing factors include age, family history, quitting smoking, lack of sleep and certain medications. Treatment includes healthy lifestyle, medications and surgery.

Report Highlights


This pipeline guide provides comprehensive information on the therapeutics under development for Obesity (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Obesity (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Obesity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 7, 30, 37, 1, 4, 145, 59 and 1 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 53 and 13 molecules, respectively.

Obesity (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope


  • The pipeline guide provides a snapshot of the global therapeutic landscape of Obesity (Metabolic Disorders)
  • The pipeline guide reviews pipeline therapeutics for Obesity (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities
  • The pipeline guide reviews key companies involved in Obesity (Metabolic Disorders) therapeutics and enlists all their major and minor projects
  • The pipeline guide evaluates Obesity (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects
  • The pipeline guide reviews latest news related to pipeline therapeutics for Obesity (Metabolic Disorders)

Reasons to Buy


  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Find and recognize significant and varied types of therapeutics under development for Obesity (Metabolic Disorders)
  • Classify potential new clients or partners in the target demographic
  • Develop tactical initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics
  • Formulate corrective measures for pipeline projects by understanding Obesity (Metabolic Disorders) pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Introduction
Obesity - Overview
  • Obesity - Therapeutics Development
  • Obesity - Therapeutics Assessment
  • Obesity - Companies Involved in Therapeutics Development
  • Obesity - Drug Profiles
  • Obesity - Dormant Projects
  • Obesity - Discontinued Products
  • Obesity - Product Development Milestones

Appendix
List of Tables
  • Number of Products under Development for Obesity, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Products under Development by Companies, 2021
  • Products under Development by Universities/Institutes, 2021
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Obesity - Pipeline by 9 Meters Biopharma Inc, 2021
  • Obesity - Pipeline by Aardvark Therapeutics Inc, 2021
  • Obesity - Pipeline by Adare Pharma Solutions, 2021
  • Obesity - Pipeline by Adipo Therapeutics LLC, 2021
  • Obesity - Pipeline by Adocia SAS, 2021
  • Obesity - Pipeline by Agentix Corp, 2021
  • Obesity - Pipeline by AgeX Therapeutics Inc, 2021
  • Obesity - Pipeline by Alla Chem LLC, 2021
  • Obesity - Pipeline by Altimmune Inc, 2021
  • Obesity - Pipeline by Amgen Inc, 2021
  • Obesity - Pipeline by Anagenesis Biotechnologies SAS, 2021
  • Obesity - Pipeline by Antag Therapeutics ApS, 2021
  • Obesity - Pipeline by AntiCancer Inc, 2021
  • Obesity - Pipeline by Aoxing Pharmaceutical Company Inc, 2021
  • Obesity - Pipeline by Applied Molecular Transport Inc, 2021
  • Obesity - Pipeline by AptamiR Therapeutics Inc, 2021
  • Obesity - Pipeline by Aptorum Group Ltd, 2021
  • Obesity - Pipeline by AstraZeneca Plc, 2021
  • Obesity - Pipeline by August Therapeutics Inc, 2021
  • Obesity - Pipeline by Auris Medical Holding Ltd, 2021
  • Obesity - Pipeline by Autotac Bio Inc, 2021
  • Obesity - Pipeline by Betagenon AB, 2021
  • Obesity - Pipeline by BioRestorative Therapies Inc, 2021
  • Obesity - Pipeline by Biozeus Pharmaceutical SA, 2021
  • Obesity - Pipeline by Boehringer Ingelheim International GmbH, 2021
  • Obesity - Pipeline by Braasch Biotech LLC, 2021
  • Obesity - Pipeline by Bristol-Myers Squibb Co, 2021
  • Obesity - Pipeline by Bukwang Pharmaceutical Co Ltd, 2021
  • Obesity - Pipeline by Caliway Biopharmaceutics Co Ltd, 2021
  • Obesity - Pipeline by Callitas Therapeutics Inc, 2021
  • Obesity - Pipeline by Can-Fite BioPharma Ltd, 2021
  • Obesity - Pipeline by Carmot Therapeutics Inc, 2021
  • Obesity - Pipeline by Cellivery Therapeutics Inc, 2021
  • Obesity - Pipeline by Centeer BioTherapeutics Ltd Co, 2021
  • Obesity - Pipeline by CinFina Pharma LLC, 2021
  • Obesity - Pipeline by Circadian Therapeutics, 2021
  • Obesity - Pipeline by CK Biotech Inc, 2021
  • Obesity - Pipeline by Clayton Biotechnologies Inc, 2021
  • Obesity - Pipeline by CohBar Inc, 2021
  • Obesity - Pipeline by Corbus Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by Corcept Therapeutics Inc, 2021
  • Obesity - Pipeline by Courage Therapeutics Inc, 2021
  • Obesity - Pipeline by CURx Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by CVI Pharmaceuticals US Inc, 2021
  • Obesity - Pipeline by Cyrus Therapeutics Inc, 2021
  • Obesity - Pipeline by D&D Pharmatech Co Ltd, 2021
  • Obesity - Pipeline by Daewoong Pharmaceutical Co Ltd, 2021
  • Obesity - Pipeline by DD Therapeutics LLC, 2021
  • Obesity - Pipeline by Diasome Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by DiscoveryBiomed Inc, 2021
  • Obesity - Pipeline by Dompe Farmaceutici SpA, 2021
  • Obesity - Pipeline by Eccogene (Shanghai) Co Ltd, 2021
  • Obesity - Pipeline by Elevian Inc, 2021
  • Obesity - Pipeline by Eli Lilly and Co, 2021
  • Obesity - Pipeline by Empros Pharma AB, 2021
  • Obesity - Pipeline by EncuraGen Inc, 2021
  • Obesity - Pipeline by Energesis Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by Enspire Bio Inc, 2021
  • Obesity - Pipeline by Enterin Inc, 2021
  • Obesity - Pipeline by Eolo Pharma, 2021
  • Obesity - Pipeline by EraCal Therapeutics AG, 2021
  • Obesity - Pipeline by ERX Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by Eternygen GmbH, 2021
  • Obesity - Pipeline by FGH BioTech Inc, 2021
  • Obesity - Pipeline by Fzata Inc, 2021
  • Obesity - Pipeline by Gan & Lee Pharmaceuticals Co Ltd, 2021
  • Obesity - Pipeline by Gila Therapeutics Inc, 2021
  • Obesity - Pipeline by Glaceum Inc, 2021
  • Obesity - Pipeline by Glucox Biotech AB, 2021
  • Obesity - Pipeline by Gmax Biopharm LLC, 2021
  • Obesity - Pipeline by GPER G-1 Development Group LLC, 2021
  • Obesity - Pipeline by Guangzhou BeBetter Medicine Technology Co Ltd, 2021
  • Obesity - Pipeline by Gubra ApS, 2021
  • Obesity - Pipeline by Gusto Global LLC, 2021
  • Obesity - Pipeline by HanAll Biopharma Co Ltd, 2021
  • Obesity - Pipeline by Hangzhou Adamerck Pharmlabs Inc, 2021
  • Obesity - Pipeline by Hangzhou Jiuyuan Gene Engineering Co Ltd, 2021
  • Obesity - Pipeline by Hanmi Pharmaceuticals Co Ltd, 2021
  • Obesity - Pipeline by HEC Pharma Co Ltd, 2021
  • Obesity - Pipeline by Huadong Medicine Co Ltd, 2021
  • Obesity - Pipeline by Ildong Pharmaceutical Co Ltd, 2021
  • Obesity - Pipeline by Immungenetics AG, 2021
  • Obesity - Pipeline by ImmunoBiome Inc, 2021
  • Obesity - Pipeline by Infusion Biosciences, 2021
  • Obesity - Pipeline by Innovimmune Biotherapeutics Inc, 2021
  • Obesity - Pipeline by Intarcia Therapeutics Inc, 2021
  • Obesity - Pipeline by Japan Tobacco Inc, 2021
  • Obesity - Pipeline by Jenrin Discovery Inc, 2021
  • Obesity - Pipeline by Jiangsu Hansoh Pharmaceutical Group Co Ltd, 2021
  • Obesity - Pipeline by Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd, 2021
  • Obesity - Pipeline by Johnson & Johnson, 2021
  • Obesity - Pipeline by Kallyope Inc, 2021
  • Obesity - Pipeline by KinDex Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by Kissei Pharmaceutical Co Ltd, 2021
  • Obesity - Pipeline by Kriya Therapeutics Inc, 2021
  • Obesity - Pipeline by Kwang Dong Pharmaceutical Co Ltd, 2021
  • Obesity - Pipeline by Lead Discovery Center GmbH, 2021
  • Obesity - Pipeline by LG Chem Ltd, 2021
  • Obesity - Pipeline by Lipidio Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by Lixte Biotechnology Holdings Inc, 2021
  • Obesity - Pipeline by MAKScientific LLC, 2021
  • Obesity - Pipeline by MD Healthcare Inc, 2021
  • Obesity - Pipeline by MeiraGTx Holdings Plc, 2021
  • Obesity - Pipeline by Merck & Co Inc, 2021
  • Obesity - Pipeline by Muen (Guangzhou) Biological Technology Co Ltd, 2021
  • Obesity - Pipeline by Nano Intelligent Biomedical Engineering Corp, 2021
  • Obesity - Pipeline by NeonMind Biosciences Inc, 2021
  • Obesity - Pipeline by NeuroNano Pharma Inc, 2021
  • Obesity - Pipeline by NGM Biopharmaceuticals Inc, 2021
  • Obesity - Pipeline by NIMIUM Therapeutics Inc, 2021
  • Obesity - Pipeline by Nordic Bioscience AS, 2021
  • Obesity - Pipeline by Novartis AG, 2021
  • Obesity - Pipeline by NovMetaPharma Co Ltd, 2021
  • Obesity - Pipeline by Novo Nordisk AS, 2021
  • Obesity - Pipeline by Nubiyota LLC, 2021
  • Obesity - Pipeline by NuSirt Biopharma Inc, 2021
  • Obesity - Pipeline by ObeTherapy Biotechnology, 2021
  • Obesity - Pipeline by Ochre Bio Ltd, 2021
  • Obesity - Pipeline by Omeros Corp, 2021
  • Obesity - Pipeline by Onegene Biotechnology Inc, 2021
  • Obesity - Pipeline by OPKO Health Inc, 2021
  • Obesity - Pipeline by Oramed Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by Orbit Discovery Ltd, 2021
  • Obesity - Pipeline by Otsuka Holdings Co Ltd, 2021
  • Obesity - Pipeline by Oxt Therapeutics Inc, 2021
  • Obesity - Pipeline by Palatin Technologies Inc, 2021
  • Obesity - Pipeline by PegBio Co Ltd, 2021
  • Obesity - Pipeline by Pfizer Inc, 2021
  • Obesity - Pipeline by Preveceutical Medical Inc, 2021
  • Obesity - Pipeline by Primetime Life Sciences LLC, 2021
  • Obesity - Pipeline by Pylum Biosciences Inc, 2021
  • Obesity - Pipeline by Qoracle Co Ltd, 2021
  • Obesity - Pipeline by Raziel Therapeutics, 2021
  • Obesity - Pipeline by Regeneron Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by Renova Therapeutics Inc, 2021
  • Obesity - Pipeline by Repurpose.AI Inc, 2021
  • Obesity - Pipeline by Resalis Therapeutics Srl, 2021
  • Obesity - Pipeline by Reviva Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by Rhamnopharma Inc, 2021
  • Obesity - Pipeline by Rhythm Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by RosVivo Therapeutics Inc, 2021
  • Obesity - Pipeline by Saniona AB, 2021
  • Obesity - Pipeline by Sanofi, 2021
  • Obesity - Pipeline by Scioto Biosciences Inc, 2021
  • Obesity - Pipeline by Sciwind Biosciences Co Ltd, 2021
  • Obesity - Pipeline by Scohia Pharma Inc, 2021
  • Obesity - Pipeline by Senda Biosciences Inc, 2021
  • Obesity - Pipeline by Seres Therapeutics Inc, 2021
  • Obesity - Pipeline by Shanghai Fosun Pharmaceutical (Group) Co Ltd, 2021
  • Obesity - Pipeline by Shionogi & Co Ltd, 2021
  • Obesity - Pipeline by Sigrid Therapeutics AB, 2021
  • Obesity - Pipeline by Siragen Pharmaceuticals Inc, 2021
  • Obesity - Pipeline by SJT Molecular Research SL, 2021
  • Obesity - Pipeline by SK Plasma Co Ltd, 2021
  • Obesity - Pipeline by Slate Bio Inc, 2021
  • Obesity - Pipeline by Soleno Therapeutics Inc, 2021
  • Obesity - Pipeline by Sun Pharmaceutical Industries Ltd, 2021
  • Obesity - Pipeline by Takeda Pharmaceutical Co Ltd, 2021
  • Obesity - Pipeline by Techfields Pharma Co Ltd, 2021
  • Obesity - Pipeline by Tryp Therapeutics Inc, 2021
  • Obesity - Pipeline by UGISense AG, 2021
  • Obesity - Pipeline by Uni-Bio Science Group Ltd, 2021
  • Obesity - Pipeline by Velabs Therapeutics GmbH, 2021
  • Obesity - Pipeline by Virtici LLC, 2021
  • Obesity - Pipeline by Vivus Inc, 2021
  • Obesity - Pipeline by XL-protein GmbH, 2021
  • Obesity - Pipeline by YSOPIA Bioscience SA, 2021
  • Obesity - Pipeline by Yuhan Corp, 2021
  • Obesity - Pipeline by Zealand Pharma AS, 2021
  • Obesity - Pipeline by Zhejiang Doer Biologics Corp, 2021
  • Obesity - Pipeline by Zihipp Ltd, 2021
  • Obesity - Pipeline by Zylem Biosciences Inc, 2021
  • Obesity - Dormant Projects, 2021
  • Obesity - Discontinued Products, 2021

List of Figures
  • Number of Products under Development for Obesity, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Routes of Administration, 2021
  • Number of Products by Stage and Routes of Administration, 2021
  • Number of Products by Top 10 Molecule Types, 2021
  • Number of Products by Stage and Top 10 Molecule Types, 2021

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 9 Meters Biopharma Inc
  • Aardvark Therapeutics Inc
  • Adare Pharma Solutions
  • Adipo Therapeutics LLC
  • Adocia SAS
  • Agentix Corp
  • AgeX Therapeutics Inc
  • Alla Chem LLC
  • Altimmune Inc
  • Amgen Inc
  • Anagenesis Biotechnologies SAS
  • Antag Therapeutics ApS
  • AntiCancer Inc
  • Aoxing Pharmaceutical Company Inc
  • Applied Molecular Transport Inc
  • AptamiR Therapeutics Inc
  • Aptorum Group Ltd
  • AstraZeneca Plc
  • August Therapeutics Inc
  • Auris Medical Holding Ltd
  • Autotac Bio Inc
  • Betagenon AB
  • BioRestorative Therapies Inc
  • Biozeus Pharmaceutical SA
  • Boehringer Ingelheim International GmbH
  • Braasch Biotech LLC
  • Bristol-Myers Squibb Co
  • Bukwang Pharmaceutical Co Ltd
  • Caliway Biopharmaceutics Co Ltd
  • Callitas Therapeutics Inc
  • Can-Fite BioPharma Ltd
  • Carmot Therapeutics Inc
  • Cellivery Therapeutics Inc
  • Centeer BioTherapeutics Ltd Co
  • CinFina Pharma LLC
  • Circadian Therapeutics
  • CK Biotech Inc
  • Clayton Biotechnologies Inc
  • CohBar Inc
  • Corbus Pharmaceuticals Inc
  • Corcept Therapeutics Inc
  • Courage Therapeutics Inc
  • CURx Pharmaceuticals Inc
  • CVI Pharmaceuticals US Inc
  • Cyrus Therapeutics Inc
  • D&D Pharmatech Co Ltd
  • Daewoong Pharmaceutical Co Ltd
  • DD Therapeutics LLC
  • Diasome Pharmaceuticals Inc
  • DiscoveryBiomed Inc
  • Dompe Farmaceutici SpA
  • Eccogene (Shanghai) Co Ltd
  • Elevian Inc
  • Eli Lilly and Co
  • Empros Pharma AB
  • EncuraGen Inc
  • Energesis Pharmaceuticals Inc
  • Enspire Bio Inc
  • Enterin Inc
  • Eolo Pharma
  • EraCal Therapeutics AG
  • ERX Pharmaceuticals Inc
  • Eternygen GmbH
  • FGH BioTech Inc
  • Fzata Inc
  • Gan & Lee Pharmaceuticals Co Ltd
  • Gila Therapeutics Inc
  • Glaceum Inc
  • Glucox Biotech AB
  • Gmax Biopharm LLC
  • GPER G-1 Development Group LLC
  • Guangzhou BeBetter Medicine Technology Co Ltd
  • Gubra ApS
  • Gusto Global LLC
  • HanAll Biopharma Co Ltd
  • Hangzhou Adamerck Pharmlabs Inc
  • Hangzhou Jiuyuan Gene Engineering Co Ltd
  • Hanmi Pharmaceuticals Co Ltd
  • HEC Pharma Co Ltd
  • Huadong Medicine Co Ltd
  • Ildong Pharmaceutical Co Ltd
  • Immungenetics AG
  • ImmunoBiome Inc
  • Infusion Biosciences
  • Innovimmune Biotherapeutics Inc
  • Intarcia Therapeutics Inc
  • Japan Tobacco Inc
  • Jenrin Discovery Inc
  • Jiangsu Hansoh Pharmaceutical Group Co Ltd
  • Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
  • Johnson & Johnson
  • Kallyope Inc
  • KinDex Pharmaceuticals Inc
  • Kissei Pharmaceutical Co Ltd
  • Kriya Therapeutics Inc
  • Kwang Dong Pharmaceutical Co Ltd
  • Lead Discovery Center GmbH
  • LG Chem Ltd
  • Lipidio Pharmaceuticals Inc
  • Lixte Biotechnology Holdings Inc
  • MAKScientific LLC
  • MD Healthcare Inc
  • MeiraGTx Holdings Plc
  • Merck & Co Inc
  • Muen (Guangzhou) Biological Technology Co Ltd
  • Nano Intelligent Biomedical Engineering Corp
  • NeonMind Biosciences Inc
  • NeuroNano Pharma Inc
  • NGM Biopharmaceuticals Inc
  • NIMIUM Therapeutics Inc
  • Nordic Bioscience AS
  • Novartis AG
  • NovMetaPharma Co Ltd
  • Novo Nordisk AS
  • Nubiyota LLC
  • NuSirt Biopharma Inc
  • ObeTherapy Biotechnology
  • Ochre Bio Ltd
  • Omeros Corp
  • Onegene Biotechnology Inc
  • OPKO Health Inc
  • Oramed Pharmaceuticals Inc
  • Orbit Discovery Ltd
  • Otsuka Holdings Co Ltd
  • Oxt Therapeutics Inc
  • Palatin Technologies Inc
  • PegBio Co Ltd
  • Pfizer Inc
  • Preveceutical Medical Inc
  • Primetime Life Sciences LLC
  • Pylum Biosciences Inc
  • Qoracle Co Ltd
  • Raziel Therapeutics
  • Regeneron Pharmaceuticals Inc
  • Renova Therapeutics Inc
  • Repurpose.AI Inc
  • Resalis Therapeutics Srl
  • Reviva Pharmaceuticals Inc
  • Rhamnopharma Inc
  • Rhythm Pharmaceuticals Inc
  • RosVivo Therapeutics Inc
  • Saniona AB
  • Sanofi
  • Scioto Biosciences Inc
  • Sciwind Biosciences Co Ltd
  • Scohia Pharma Inc
  • Senda Biosciences Inc
  • Seres Therapeutics Inc
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd
  • Shionogi & Co Ltd
  • Sigrid Therapeutics AB
  • Siragen Pharmaceuticals Inc
  • SJT Molecular Research SL
  • SK Plasma Co Ltd
  • Slate Bio Inc
  • Soleno Therapeutics Inc
  • Sun Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical Co Ltd
  • Techfields Pharma Co Ltd
  • Tryp Therapeutics Inc
  • UGISense AG
  • Uni-Bio Science Group Ltd
  • Velabs Therapeutics GmbH
  • Virtici LLC
  • Vivus Inc
  • XL-protein GmbH
  • YSOPIA Bioscience SA
  • Yuhan Corp
  • Zealand Pharma AS
  • Zhejiang Doer Biologics Corp
  • Zihipp Ltd
  • Zylem Biosciences Inc